Issue 9, 2019

Resisting resistance: gearing up for war

Abstract

Where do we stand in our fight against antimicrobial resistance (AMR)? Many antimicrobials may lose their clinical efficacy, particularly due to the rise of multidrug-resistant (MDR) and extended drug-resistant (XDR) pathogens, including bacteria, fungi, and parasites. We need weapons against them all. Society must come together against these pathogens, just like we did against HIV, cancer, and heart disease. This opinion piece is, first and foremost, a call to arms for all partners involved in the war against AMR. Even more so, it is an attempt to highlight the positives in a seemingly long line of failures, and to identify the current set of challenges we must work on. So, how do we win the war against AMR? We must learn from the past, so we can act in the present, to save the future.

Graphical abstract: Resisting resistance: gearing up for war

Article information

Article type
Opinion
Submitted
14 Jun 2019
Accepted
25 Jul 2019
First published
07 Aug 2019

Med. Chem. Commun., 2019,10, 1512-1516

Resisting resistance: gearing up for war

A. Sarkar and S. Garneau-Tsodikova, Med. Chem. Commun., 2019, 10, 1512 DOI: 10.1039/C9MD00330D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements